Literature DB >> 30474783

Feasibility of a novel technique using 3-dimensional modeling and augmented reality for access during percutaneous nephrolithotomy in two different ex-vivo models.

Murat Akand1,2, Levent Civcik3, Ahmet Buyukaslan4, Emre Altintas5, Erdinc Kocer6, Mustafa Koplay7, Tibet Erdogru8.   

Abstract

PURPOSE: We describe a novel technique that uses mathematical calculation software, 3-dimensional (3D) modeling and augmented reality (AR) technology for access during percutaneous nephrolithotomy (PCNL) and report our first preliminary results in two different ex-vivo models.
METHODS: Novel software was created in order to calculate access point and angle by using pre-operative computed tomography (CT) obtained in 50 patients. Two scans, 27 s and 10 min after injection of contrast agent, were taken in prone PCNL position. By using DICOM objects, mathematical and software functions were developed to measure distance of stone from reference electrodes. Vectoral 3D modeling was performed to calculate the access point, direction angle and access angle. With specific programs and AR, 3D modeling was placed virtually onto real object, and the calculated access point and an access needle according to the calculated direction angle and access angle were displayed virtually on the object on the screen of tablet.
RESULTS: The system was tested on two different models-a stone placed in a gel cushion, and a stone inserted in a bovine kidney that was placed in a chicken-for twice, and correct access point and angle were achieved at every time. Accuracy of insertion of needle was checked by feeling crepitation on stone surface and observing tip of needle touching stone in a control CT scan.
CONCLUSIONS: This novel device, which uses software-based mathematical calculation, 3D modeling and AR, seems to ensure a correct access point and angle for PCNL. Further research is required to test its accuracy and safety in humans.

Entities:  

Keywords:  3-Dimensional; Access; Augmented reality; Modeling; Percutaneous nephrolithotomy; Software

Mesh:

Year:  2018        PMID: 30474783     DOI: 10.1007/s11255-018-2037-0

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  5 in total

Review 1.  Percutaneous puncture during PCNL: new perspective for the future with virtual imaging guidance.

Authors:  E Checcucci; D Amparore; G Volpi; F Piramide; S De Cillis; A Piana; P Alessio; P Verri; S Piscitello; B Carbonaro; J Meziere; D Zamengo; A Tsaturyan; G Cacciamani; Juan Gomez Rivas; S De Luca; M Manfredi; C Fiori; E Liatsikos; F Porpiglia
Journal:  World J Urol       Date:  2021-09-01       Impact factor: 3.661

Review 2.  New Technologies for Kidney Surgery Planning 3D, Impression, Augmented Reality 3D, Reconstruction: Current Realities and Expectations.

Authors:  Francesco Esperto; Francesco Prata; Ana María Autrán-Gómez; Juan Gomez Rivas; Moises Socarras; Michele Marchioni; Simone Albisinni; Rita Cataldo; Roberto Mario Scarpa; Rocco Papalia
Journal:  Curr Urol Rep       Date:  2021-05-25       Impact factor: 3.092

Review 3.  Techniques for fluoroscopy-guided percutaneous renal access: An analytical review.

Authors:  Gyanendra Ravindra Sharma; Bhojraj Luitel
Journal:  Indian J Urol       Date:  2019 Oct-Dec

Review 4.  Review of the effect of 3D medical printing and virtual reality on urology training with ‘MedTRain3DModsim’ Erasmus + European Union Project

Authors:  İlkan Tatar; Emre Huri; İlker Selçuk; Young Lee Moon; Alberto Paoluzzi; Andreas Skolarikos
Journal:  Turk J Med Sci       Date:  2019-10-24       Impact factor: 0.973

5.  3D Reconstruction and physical renal model to improve percutaneous punture during PNL.

Authors:  Lorenzo Bianchi; Riccardo Schiavina; Umberto Barbaresi; Andrea Angiolini; Cristian V Pultrone; Fabio Manferrari; Barbara Bortolani; Laura Cercenelli; Marco Borghesi; Francesco Chessa; Elisa Sessagesimi; Caterina Gaudiano; Emanuela Marcelli; Eugenio Brunocilla
Journal:  Int Braz J Urol       Date:  2019 Nov-Dec       Impact factor: 1.541

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.